NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025

NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its third quarter 2025 financial results prior to the open of the U.S. financial markets on Tuesday, October 28, 2025. Company management will host a webcast and conference call at 8:30 a.m. ET to discuss financial results and recent highlights.

The live webcast may be accessed by visiting the Investor Relations section of our website at ir.neogenomics.com or by clicking here . The webcast will be archived and available for replay shortly after the conclusion of the call.

To access the live call via telephone, dial (888) 506-0062 (domestic) or (973) 528-0011 (international) at least five minutes prior to the call. The participant access code is 392611.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. Headquartered in Fort Myers, FL, NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories for full-service sample processing and analysis services throughout the US and a CAP-accredited full-service sample-processing laboratory in Cambridge, United Kingdom.

Investor Contact
Kendra Webster
ir@neogenomics.com

Media Contact
Andrea Sampson
asampson@sampsonprgroup.com

News Provided by Business Wire via QuoteMedia

NEO
The Conversation (0)
AMERICAN SALARS ADDS LITHIUM BRINE EXPERT DR. MARK KING AS A TECHNCIAL ADVISOR AND QUALIFIED PERSON

AMERICAN SALARS ADDS LITHIUM BRINE EXPERT DR. MARK KING AS A TECHNCIAL ADVISOR AND QUALIFIED PERSON

American Salars Lithium Inc. ("AMERICAN SALARS" OR THE "COMPANY") (CSE: USLI, OTC: ASALF, FWB: Z3P, WKN: A3E2NY ) announces the addition of Dr. Mark King PhD, PGeo, FGC, a world-renowned lithium brine expert, as a Technical Advisor and Qualified Person. Dr. King is a hydrogeologist with 30+... Keep Reading...
Trigg Minerals Limited

Trigg Expands Tier-1 Australian Antimony-Gold Tenure with Grades up to 61% Sb & 1045 g/t Au

New acquisition complements Trigg’s flagship WCC deposit and the Company’s vision to become a primary antimony play and future global supplier of antimony

Trigg Minerals Limited (ASX: TMG| OTCQB: TMGLF) ("Trigg" or the "Company") is pleased to announce the acquisition of the Nundle, Upper Hunter and Cobark/Copeland Projects, a highly prospective tenement package covering a significant portion of the historic Nundle Goldfield and three additional... Keep Reading...
Expanded Materials and Technology Updates Bring New Opportunities for Stratasys Customers to Boost Their Additive Manufacturing Capabilities

Expanded Materials and Technology Updates Bring New Opportunities for Stratasys Customers to Boost Their Additive Manufacturing Capabilities

OpenAM and new materials for FDM, along with software upgrades are part of new solutions customers have available Stratasys Ltd. (NASDAQ: SSYS) is announcing updates to several Industrial and Healthcare Business Unit products and Stratasys Direct. These include a new open platform for the F900™... Keep Reading...
SIGMA LITHIUM JOINS VICE PRESIDENTIAL TRADE MISSION TO CHINA IN BEIJING; PARTICIPATES IN ASPEN INSTITUTE-COLUMBIA UNIVERSITY GLOBAL ENERGY FORUM IN BRAZIL

SIGMA LITHIUM JOINS VICE PRESIDENTIAL TRADE MISSION TO CHINA IN BEIJING; PARTICIPATES IN ASPEN INSTITUTE-COLUMBIA UNIVERSITY GLOBAL ENERGY FORUM IN BRAZIL

HIGHLIGHTS Sigma Lithium has been honored with the participation in a trade mission to China invited by ApexBrasil, the export and investment trade agency of the Brazilian Government, from June 5 – 7 th , during COSBAN, to mark the 50 th anniversary of diplomatic relations between the countries... Keep Reading...
Imagion Biosystems

Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging technology, is pleased to provide shareholders with a progress update regarding the Company’s business and... Keep Reading...
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare. But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no... Keep Reading...
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This... Keep Reading...
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access... Keep Reading...
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will... Keep Reading...
HeartSciences Inc

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration with Hospital EHR Systems

Latest Press Releases

Related News